[6] DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer

Jan 1, 2018·
Y Meng
,
CW Chen
,
MMH Yung
,
W Sun
,
J Sun
,
Z Li
,
J Li
,
Z Li
,
W Zhou
,
et al.
· 0 min read
Type
Publication
Cancer Letters
publications